What Hospitech Respiration does

Hospitech Respiration Ltd is an Israeli medical device company founded in 2006, headquartered in Kfar Saba with an additional office in Petah Tikva. The company develops and commercializes the AnapnoGuard platform, an integrated airway management solution for mechanically ventilated patients in hospital and ICU settings. Its core technology combines continuous CO2 monitoring in the subglottic space with closed-loop automated cuff pressure control, enabling real-time adjustment of endotracheal tube cuff pressure based on physiological leak detection. The system pairs the reusable AG100s Control Unit (capital equipment) with a disposable triple-lumen AG Endotracheal Tube featuring a thin-walled polyurethane cuff, allowing simultaneous subglottic rinsing and secretion evacuation to reduce ventilator-associated pneumonia and tracheal tissue injuries. Manual alternatives (AG Cuffill manometer and AG MASS suction device) serve settings where the automated unit is unavailable.

The company's revenue model is based on hardware sales, combining capital equipment placement with recurring disposable tube consumption tied to ventilated patient volume. Hospitech commercializes through a hybrid go-to-market approach: direct sales to hospital procurement and clinical departments supplemented by distribution partnerships, most notably the March 2024 divestiture of the AG Cuffill product line to Medline Industries for global channel distribution. The company holds US FDA 510(k), European CE Mark, and China CFDA regulatory approvals, and reports commercial presence in over 35 countries across Europe, the Americas, Asia-Pacific, and Oceania. Multiple peer-reviewed clinical studies and randomized controlled trials support the platform's safety and efficacy claims, serving as a primary marketing and differentiation lever in clinical procurement decisions.

Name

Hospitech Respiration

Legal name

Hospitech Respiration Ltd.

Website

https://hospitech.co.il

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Hospitech Respiration is an Israeli medical device company that develops the AnapnoGuard platform, providing automated endotracheal tube cuff pressure control and subglottic secretion evacuation for mechanically ventilated patients in hospitals and ICUs across 35+ countries.

Ownership category

akta.pro rank

Product category

Airway Management Medical Devices

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

Ventilators & Mechanical Ventilation Systems (ICU/Transport/Home) (HLAHAGAC)

akta.pro secondary industries

Suction, Irrigation & Fluid Management Systems (HLAHADAK), Respiratory Monitoring & Oximetry (Capnography, Pulse Oximeters, Respiratory Rate) (HLAHAGAI)

Keywords

• Airway management devices
• Mechanical ventilation products
• Endotracheal tubes
• Cuff pressure control
• Subglottic secretion evacuation

Headquarters

HQ city

Kfar Saba

HQ country

Israel

HQ region

Middle East

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Marketing or Sales, Operations

Revenue model

1. AnapnoGuard AG100s Control Unit (Capital Equipment): The AG100s Control Unit is a reusable hardware device sold as capital equipment to hospitals and ICUs. The device provides automated cuff pressure control and subglottic secretion management for mechanically ventilated patients.
2. AG Endotracheal Tube (Disposables): The AnapnoGuard Endotracheal Tube is a single-use disposable device. The AG MASS is also a single-use device for manual secretion management. These create recurring disposable revenue tied to the volume of mechanically ventilated patients.
3. AG Cuffill Manual Digital Manometer: The AG Cuffill is a manual digital manometer sold as a single-use or reusable device for easy monitoring and adjustment of ET Tube cuff pressure. This product was licensed/acquired by Medline for broader distribution.

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Hospitech Respiration develops and commercializes the AnapnoGuard platform for airway management in mechanically ventilated patients. The platform combines the reusable AG100s Control Unit, which uses continuous CO2 monitoring in the subglottic space to automatically adjust endotracheal tube cuff pressure, with a triple-lumen AG Endotracheal Tube that simultaneously rinses and evacuates subglottic secretions. Disposable accessories include the AG MASS manual suction device and the AG Cuffill digital manometer for use when the automated control unit is not available.

Product overview

Hospitech Respiration provides the AnapnoGuard platform, an innovative therapeutic solution for mechanically ventilated patients. The platform consists of automated and disposable devices: the AG100s Control Unit (the core automated system) works in conjunction with the AG Endotracheal Tube to provide automated cuff pressure control and effective subglottic secretion evacuation. When the automated system is unavailable, clinicians can use manual alternatives including the AG Cuffill (manual manometer) and AG MASS (single-use suction device).

Differentiator

Problem solved

Functional benefit

Brands

• AnapnoGuard: Automated ET Tube cuff pressure control and subglottic secretion evacuation solution for mechanically ventilated patients, consisting of the AG100s Control Unit and AG Endotracheal Tube.
• AG100s
• AG Endotracheal Tube

Products and services

• AnapnoGuard AG100s Control Unit Integrated, multi-purpose airway management system providing automated endotracheal tube cuff pressure control through closed-loop CO2 monitoring and effective evacuation of subglottic secretions via simultaneous rinsing and suction; sold as capital equipment to hospitals and intensive care units managing mechanically ventilated patients.
• AG Endotracheal Tube Single-use disposable advanced endotracheal tube with three unique lumens (two for suction, one for venting/rinsing) and a thin-walled polyurethane cuff with advanced sealing properties, designed to prevent complications from prolonged mechanical ventilation including infections and tracheal injury in critically ill intubated patients.
• AG Cuffill Manual digital manometer for easy monitoring and adjustment of endotracheal tube cuff pressure when the automated AG100s Control Unit is not available; distributed via Medline Industries following its 2024 acquisition of the AG Cuffill product line from Hospitech.
• AG MASS Single-use device for manual rinsing and suction of subglottic secretions used in clinical settings where the automated AnapnoGuard AG100s Control Unit is not available, supporting subglottic secretion management to help prevent ventilator-associated pneumonia.

Quantifiable outcome

• In the De Pascale et al. randomized controlled study (2017), use of the AnapnoGuard AG100 system was found to be safe and effective for automated cuff pressure control and subglottic secretion drainage in critically ill intubated patients.

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

One partnership is on record.

• Medline Industries, LPcoreChannel Partner/ Reseller/ Distributor · 20 March 2024In March 2024, Medline Industries LP acquired the AG Cuffill product line from Hospitech Respiration Ltd. The acquisition reflects a strategic partnership where Hospitech leverages Medline's extensive global distribution network to commercialize its airway management products. Medline committed to retaining AG Cuffill as an integral part of its market-leading airway management portfolio, with Hospitech CEO Yoav Venkert expressing commitment to further cooperation with Medline to commercialize more of its product portfolio.

Scale indicators1 record

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Teleflex: Teleflex is a major airway management incumbent with a broad portfolio of endotracheal tubes (including subglottic suction tubes like the Iso-Gard) and is one of the dominant competitors Hospitech faces in ICU ET tube purchasing decisions globally.
• Smiths Medical: Smiths Medical (ICU Medical) markets Portex endotracheal tubes and other airway management devices into hospitals, providing a multi-product incumbent alternative to the AnapnoGuard platform in ICU airway management.
• Ambu: Ambu is a publicly listed specialist in single-use devices including airway management and anesthesia products, competing with Hospitech's disposable ET tube offering in hospital and ICU channels globally.
• Medtronic (Covidien): Medtronic's Respiratory Interventions business (inheriting Covidien's portfolio) offers Shiley endotracheal tubes and related airway management products sold directly into ICUs, representing a large-scale incumbent competing for the same procurement budgets as Hospitech.
• Cook Medical: Cook Medical manufactures a range of airway management and critical care devices sold into hospital and ICU channels, representing an additional broad incumbent in the same hospital procurement environment Hospitech targets.

Others

• Medline Industries: Medline Industries is Hospitech's channel partner and acquired the AG Cuffill product line; Medline is also a major distributor/manufacturer of competing airway management products and represents both an enabler and a potential competitor in the same hospital accounts.

Direct peers

• VBM Medizintechnik: VBM Medizintechnik manufactures cuff pressure gauges/manometers (e.g., Cuff Pressure Gauge) and airway management accessories, directly overlapping with Hospitech's AG Cuffill manual manometer product concept in the same clinical use case.
• Intersurgical: Intersurgical is a European-based respiratory care and airway management device manufacturer offering endotracheal tubes, suction devices, and related consumables, directly competing with Hospitech in the ICU ET tube category across similar geographies.

Regional players

• TRACOE Medical: TRACOE Medical specializes in tracheostomy and airway management devices, addressing similar patient populations (intubated and tracheostomized ICU patients) and competing in selected European markets where Hospitech also sells.

Emerging players

• Venner Medical (PneuX): Venner Medical has developed the PneuX endotracheal tube with subglottic secretion drainage and continuous cuff pressure monitoring, a direct technical and clinical competitor to AnapnoGuard's combined cuff pressure + secretion evacuation approach.

Market position

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/hospitech-respiration

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds1 record

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hospitech Respiration